Abbott Nutrition Sales Decline but Show Sequential Improvement

Dow Jones
07/16

Abbott's Nutrition segment reported a 3.1% sales decline in the second quarter, with comparable sales down 3.6%. The company attributes the drop to lower sales volumes compared to the prior year and strategic pricing actions implemented in the fourth quarter of 2025. U.S. Pediatric Nutrition fell 10.7%, while international pediatric sales rose 7.3%. There's a sequential uptick, however: Nutrition sales increased $127 million from the first quarter of 2026. Abbott says the pricing actions and new product launches are contributing to improving performance

 

This article was automatically created using artificial-intelligence technology and reviewed by Dow Jones Newswires editors.

 

(END) Dow Jones Newswires

July 16, 2026 08:19 ET (12:19 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10